Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
B. Curtis
Observed names:
B Curtis,
B. H. Curtis,
B.H. Curtis,
Curtis, B. H.
Institution:
Eli Lilly (United States)
Observed institution:
Eli Lilly (United States)
OpenAlex ID:
A5111098400
Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme
2016
·
S M Babineaux
, B Curtis
, et al.
·
BMJ Open
·
259
PDF
Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics
2013
·
J. M. Khalid
, M. Raluy‐Callado
, et al.
·
International Journal of Clinical Practice
·
106
PDF
Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin
2012
·
B. T. Blak
, H. T. Smith
, et al.
·
Diabetic Medicine
·
50
Changes and predictors for change to thiazolidinedione prescribing in UK primary care following the rosiglitazone safety warning
2011
·
G. C. Hall
, H. T. Smith
, et al.
·
International Journal of Clinical Practice
·
9
Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK
2015
·
W.J. Valentine
, B.H. Curtis
, et al.
·
Diabetes Research and Clinical Practice
·
7
Evidence for Validity of a National Physician and Patient-Reported Survey in China and United Kingdom: The Disease Specific Programme
2014
·
S.M. Babineaux
, B.H. Curtis
, et al.
·
Value in Health
·
6
Incidence of non‐severe hypoglycaemia and intensity of treatment among veterans with Type 2 diabetes in the USA: a prospective observational study
2014
·
C. S. Wendel
, G. G. Fotieo
, et al.
·
Diabetic Medicine
·
6
Predicting the Frequency of Severe and Non-Severe Hypoglycaemia in Insulin Treated Type-2 Diabetes Subjects
2013
·
P. McEwan
, V. Foos
, et al.
·
Value in Health
·
4
Anti‐CD3 monoclonal antibody treatment in newly diagnosed Type 1 diabetes patients: a hypothetical modelling analysis
2009
·
J. Smith‐Palmer
, B. H. Curtis
, et al.
·
Diabetic Medicine
·
4
Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with Insulin
2013
·
V. Foos
, D. Grant
, et al.
·
Value in Health
·
1
PSY44 Association of the Obesity and Weight-Loss Quality-of-Life Score With Patient Demographics and Measures of Obesity
2011
·
L.J. Lee
, D.R. Nelson
, et al.
·
Value in Health
·
1
Differences in persistence by class of oral therapy for the treatment of type 2 diabetes
2016
·
AP McGovern
, William Hinton
, et al.
·
Diabetologia
Modeling the Long Term Economic Benefits of a Patient-Adjusted Mealtime Insulin Titration Algorithm among Patients with Type 2 diabetes in the united States
2015
·
N.O. Numapau
, D.R. Murphy
, et al.
·
Value in Health
Heterogeneity of health care costs among medicare advantage patients with type 1 diabetes
2014
·
G.S. Clore
, S.L. Slabaugh
, et al.
·
Value in Health
Identifying factors associated with hypoglycemia-related hospitalization among elderly patients with T2DM in the united states: A novel approach using influential variable analysis
2014
·
B.H. Curtis
, D.P. Schuster
, et al.
·
Value in Health
Clinical Outcomes Of A Pharmacist And Nurse Pilot Intervention In A Commercial Population
2014
·
J.S. Lee
, P. Sun
, et al.
·
Value in Health
PHP7 Health Care Decision Making in Mainland China, Korea, and Taiwan: The Road Ahead?
2012
·
B. Mitchell
, B. Curtis
, et al.
·
Value in Health
PDF
PDB55 Estimating the Cost-Effectiveness of Premixed Analog Insulin Versus Long Acting Analog Basal Insulin and Premixed Human Insulin in the Management of Type 2 Diabetes: A Long Term Analysis in the United Kingdom (UK)
2012
·
B. Curtis
, R. Pollock
, et al.
·
Value in Health
PDF
PDB79 Application of the Subgroup Identification Tool Using a Health Care Database: Treatment Response Heterogeneity in Type II Diabetes
2011
·
L. Chen
, D. Buesching
, et al.
·
Value in Health
Pmd11 Identifying Potential Drivers of Cost Savings With Insulin Administration Devices in Type-2 Diabetes in the United States
2011
·
R.F. Pollock
, B. Curtis
, et al.
·
Value in Health
PDF
Utilities for Infusion Therapy in Type 1 Diabetes
2009
·
Lloyd, A.
, Swinburn, P.
, et al.
·
Research Portal (King's College London)
Show more works
View as search
Works count:
21
Citation count:
453
H-index:
6
I10-index:
3
Year
Topic
Type